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model, after the ischemic event. These results might shed light onto a pharmacological 
strategy for the treatment of patients with acute myocardial infarction. 
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1145-100 Trimetazidine-Mediated Cardioprotection During 
lschemia Is Mediated by Mitochondrial Respiratory 
Chain’s Complex I Activity 
Pedro Mont&o, Paula J. Oliveira, Lino M. Goncalves, Luis A. Providencia, Basic 
Research Unit Coimbra University Hospital, Coimbra, Portugal 
Trimetazidine (TMZ) was reported to protect myocardium from ischemia by mechanisms 
not fully understood. To better understand them, we used an ex-viva model of global 
myocardlal ischemla, perfused in a Langendorf apparatus. Thirty Wistar rat hearts were 
divided in 3 groups: A - 180 minutes of perfusion with a modified Krebs solution, 6 60 
minutes of p&won with the same solution. followed by 120 minutes of ischemia, in the 
absence of glucose and 0, and C - as in 8, but in the presence of TMZ 25 @ M. Mito- 
chondria were then isolated and used to determine the activity of complexes I, II-111 and 
IV of the mitochondrial respiratory chain (MRC). Parameters evaluated were: Respiratory 
Control Ratio (RCR), Mitochondrial Membrane’s Electrical Potential (A Y ), Phosphoryla- 
tive Lag Phase (PLP) and Enzymatic Activities (EA) of MRC’s complexes. 
TMZ significantly Improved the EA of MRC’s complex I, resulting in higher RCR and A Y 
values, wthout any significant change in PLP. 
In conclusion, TMZ improved the efficiency of the oxidative system, with a better preser- 
vation of the electrochemical gradient within the inner mitochondrial membrane. It is for 
the first time shown that these mechanisms, involved in the cardioprotective effect of 
TMZ, are dependent on an increase in Complex I activity. 
Table legend: * - p&O5 lschemic vs TMZ; values are expressed as % of control (Group 
AI. 
Table I-Results 
Groups/Parameters 
RCR 
A Y (Glutamata/Malate) 
EA _ Complex I 
EA Complexes 11-111 
EA Complex IV 
lschemic 
56- 5% 
89- 2% 
63* 5% 
60+ 5% 
71* 7% 
l?.Q 
lOl+ 16%. 
95+ 1% * 
154* 11%’ 
66* 4% 
71+ 5% 
1145-101 Inhibition of Delta Protein Kinase C Protects Vascular 
Injury and Microcirculation From Reperfusion Injury in 
Myocardial Infarction 
Fumiaki Ikeno, Kolchi Inagaki, Leon Chen, Erik T. Price, Ralph C. Fenn. Alan C. Yeung, 
Dada Mochly-Rosen, Mehrdad Rezaee, Stanford University, Stanford, CA 
Ob@ctive: No pharmacological therapies have been developed to protect the heart from 
ischemlc-reperfusion(IR) injury ,although therapies for acute myocardial infarction are 
directed toward tamely reperfusion thrombolytic agents and mechanical interventions. 
dProtein kmese-C(PKC) is thought to play a critical role in the mechanism of IR injury. 
We have developed isozyme-selective dPKC inhibitor(dVl-I) [conjugated by a reversible 
Cys-Cys bond to a cell permeable carrier peptide, Tat]. Previously dVl-1 was shown to 
decrease infarct size when applied at the time of reperfusion. The present study was per- 
formed to determine the potential effect this inhibitor in protection against microvascular 
damage induced by IR. 
Methods and Results: Utilizing a Langendorfl model of ischemic injury(20 min) followed 
by IR(30 min) in rat hearis(w7)‘). delivery of dVl-1 during the first IO min reperfusion 
demonstrated improved coronary vascular resistance(CVR)(9.6+0.8 vs. 12.8+0.5 
mmHg’min/mL, p<O.O05) , reduced infarcted s&(42+8 vs 12+2, ~~0.005) compared 
with control(n=7). 
Utilizing a clinically relavant model of acute porcine(n=li) coronary ischemia(30min) 
usmg a balloon catheter inflated in the LAD artery followed by local delivery of dVl- 
l(5pM) durtng the final 1 minute of ischemia preserved Coronary flow 
researve(2.00+0.20 vs 1.51+0.12 at 30min, 2.73+0.37 YS 1.28+0.08 at 4hr, 2.94+0.24 vs 
1.82+0.19 at 5 days, p&01), reduced infarcted size(4.3t0.8 vs 31:4+5.3, p<O.OOl) com- 
pared with control(n=l I). Myocardial Contrast Echocardiography at 4 hr showed contrast 
deficit in risk area in control but not I” dVl-1. TUNEL and CD31 or a-acctinln co-stain 
showed the evidences dVl-1 reduced apoptosis in vascular endothelial cells and myo- 
cytes and dVl-1 reduced 60% of apoptosis. 
Conclusion: Microvascuar function preservation and reduced infarcted size can be 
1145-102 Oxygen Free Radical Scavengers Reverse Alterations to 
Multiple Proteins Observed Following Myocardial 
Stunning 
Melanie Y. White, Stuart J. Cordwell, Hugh C. McCarron. Adrian S. Tchen. George E. 
Craft, Brett D. Hambly, Richmond W. Jeremv, The University of Sydney, Sydney, 
Australia, Australian Proteome Analysis Facility, Sydney, Australia 
Background:The precise mechanisms that result in myocardium being reversibly dam- 
aged (myocardial stunning) as a consequence of brief ischemia followed by reperfusion 
remain unresolved. Previous studies indicate a role for both oxygen free radical (OFR) 
formation and intracellular calcium overload in the pathogenesis of stunning. The rela- 
tively short time course for the onset of injury suggests that modifications to key proteins 
may lead to the clinical manifestation. We have utilised proteomics to investigate the 
molecular basis of stunning and show alterations to multiple proteins may be reversed by 
scavenging OFRs. Methods: Left ventricular (LV) samples were taken from rabbit hearts 
after either 75 min control perfusion or 15 mln low flow (1 mllmin) ischemia followed by 
60 min reperiusion (151/60R). A final group underwent 151/60R, with OFR scavenger, N- 
(2-mercaptopropionyl) glycine (MPG, 3mM) added (n=6/group). lsovolumetric LV pres- 
sure was measured throughout. Protein profiles were generated by two-dimensional 
electrophoresis (2-DE) and mass spectrometry to identify differentially expressed pro- 
tams. Results: Rate pressure product (RPP, % baseline) at the end of the protocol was 
impaired in 151/60R (61+/- 6 %, pcO.01) compared to control, consistent with stunning. In 
contrast. RPP was preserved in the MPG protected hearts (106+/- 9 %, NS). Compara- 
tive analysis revealed 37 differences (> 2-fold difference in expression) from 5 functional 
groups (sarcomeric, cytoskeletal, mitochondrial, redox regulation and ion transport). 
These differences may be the result of post translational modifications, for instance frag 
mentation. The modifications to myosin light chain-2. alpha actinin and Na/K ATPase 
were reversed by the addition of MPG. Conclusion: The molecular mechanism of stun- 
ning is most likely a multifactorial process, involving damage to and /or alteration of sev- 
eral key protein systems. This study shows that scavenging of OFR results in the 
amelioration of some of these modifications. 
1145-103 Powerful Microvascular and Myocardial Protection by 
NadH+-Exchange Inhibition and lschemic 
Preconditioning: Evidence for a Causal Link in the 
Rabbit 
Thorsten Reffelmann. Robert A. Kloner, The Heart Institute. Good Samaritan Hospital, 
University of Southern California, Los Angeles, CA 
Objectives and Background:Two independent cardioprotective interventions, ischemic 
preconditioning (PC) and N&/H+-exchange inhibition (cariporide (Cp) 300 @kg), were 
studied with respect to their differential effects on microvascular and myocardial salvage. 
Methods: Infarct size (IS, triphenyltetrazolium) (% risk area (RA, blue dye)) was related 
to anatomic no-reflow (ANR, thioflavin S injection at the end of reperfusion), and regional 
myocardial blood flow (RMBF, radioactive microspheres, 30 and 180 min of reperiusion) 
in 52 anesthetized rabbits (30 min coronary occlusion, 180 min reparfusion). Results: 
PC and Cp prior to occlusion (protocol 1) markedly reduced IS (by 40%, 62%“, raspec- 
tively) and ANR (by 34% ‘, 53% “), which was accompanied by increased RMBF with 
both treatments. However, neither intervention uncoupled the close relationship (r=0.92- 
0.95) between IS and ANR, nor between IS and blood flow (ANCOVA). Importantly, Cp, 
given 5 min before reperiusion (protocol 2). did not alter IS, ANR, RMBF or their close 
interrelationship. Conclusions: Despite pronounced microvascular and myocardial pro- 
tection, neither intervention uncoupled the close correlation between ANR and IS, sug- 
gestlng a causal link between myocardial and microvascular salvage. 
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